V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009113 | 310003904 | 1.6 | 69 | Neo-adjuvant (N) | 2015-04-16 | 2015-04-18 | Bevacizumab | N | N | 310008748 | BEVACIZUMAB |
| 310009114 | 310003905 | 1.56 | 83.4 | Not known (9) | 2016-04-13 | 2016-04-13 | Bevacizumab 7.5mg/kg | N | N | 310008767 | BEVACIZUMAB |
| 310009115 | 310003905 | 1.73 | 69.05 | Palliative (P) | 2015-12-05 | 2015-12-19 | Liposomal Doxorubicin 40mg/m2 | N | null | 310008767 | LIPOSOMAL DOXORUBICIN |
| 310009116 | 310003906 | 1.66 | 86 | Palliative (P) | 2013-06-27 | 2013-07-11 | Trial Unspecified | N | null | 310008825 | TRIAL |
| 310009117 | 310003909 | 1.8 | 71.1 | Neo-adjuvant (N) | 2016-09-12 | 2017-02-15 | Bevacizumab 7.5mg/kg | N | N | 310008825 | BEVACIZUMAB |
| 310009119 | 310003913 | 1.75 | 78.6 | Palliative (P) | 2014-08-05 | 2015-01-01 | CHOP | 02 | N | 310008857 | CHOP |
| 310009120 | 310010599 | 1.58 | 73 | null | 2018-09-23 | 2018-10-01 | Bevacizumab 7.5mg/kg | N | N | 310008897 | BEVACIZUMAB |
| 310009121 | 310003916 | 1.46 | null | Palliative (P) | 2015-08-21 | 2015-09-01 | Bevacizumab | N | N | 310008911 | BEVACIZUMAB |
| 310009123 | 310003921 | 1.6 | 63.8 | Adjuvant (A) | 2017-07-15 | 2017-07-17 | Trial Unspecified | N | null | 310009019 | TRIAL |
| 310009124 | 310007612 | 1.71 | 138 | Palliative (P) | 2017-02-25 | 2017-02-25 | CARBOPLATIN + GEMCITABINE | N | N | 310009019 | GEMCARBO |
| 310009125 | 310003923 | 1.65 | 57.2 | Neo-adjuvant (N) | 2015-05-13 | 2015-05-13 | Bevacizumab 7.5mg/kg | 2 | N | 310009079 | BEVACIZUMAB |
| 310009126 | 310003926 | 1.67 | null | Curative (C) | 2018-08-19 | 2018-08-19 | CHOP | N | null | 310009084 | CHOP |
| 310009127 | 310003928 | 1.73 | 109.8 | Curative (C) | 2015-08-25 | 2015-09-01 | Liposomal Doxorubicin (Caelyx) | N | N | 310009205 | LIPOSOMAL DOXORUBICIN |
| 310009129 | 310003931 | 1.72 | 68.9 | Curative (C) | 2015-12-09 | 2015-12-10 | Bevacizumab 15mg/kg | N | N | 310009227 | BEVACIZUMAB |
| 310009130 | 310003933 | 1.81 | null | Disease modification (D) | 2017-12-28 | 2018-01-08 | CHOP | 02 | N | 310009231 | CHOP |
| 310009131 | 310003937 | 1.7 | 7 | Palliative (P) | 2015-07-03 | 2015-07-03 | GemCarbo Days 1+8 | 2 | N | 310009285 | GEMCARBO |
| 310009132 | 310011512 | null | 51.9 | Palliative (P) | 2012-07-01 | 2015-02-12 | Liposomal Doxorubicin 40mg/m2 | N | N | 310009386 | LIPOSOMAL DOXORUBICIN |
| 310009134 | 310003944 | 1.58 | null | Palliative (P) | 2017-02-02 | 2017-02-20 | GEMCARBO | 02 | N | 310009430 | GEMCARBO |
| 310009135 | 310003947 | -1 | null | Palliative (P) | 2017-05-27 | 2017-06-12 | Liposomal Doxorubicin (Caelyx) | N | N | 310009438 | LIPOSOMAL DOXORUBICIN |
| 310009136 | 310007626 | 1.73 | 54.2 | Palliative (P) | 2015-07-18 | 2015-08-03 | Trial Unspecified | 01 | N | 310009534 | TRIAL |
| 310009137 | 310007626 | 1.73 | null | Disease modification (D) | 2016-01-31 | 2016-02-03 | Bevacizumab | N | N | 310009534 | BEVACIZUMAB |
| 310009138 | 310003953 | 1.72 | null | Adjuvant (A) | null | 2018-07-22 | CHOP - 14 days | N | N | 310009650 | CHOP |
| 310009139 | 310003955 | 1.66 | 109.7 | null | 2014-12-08 | 2014-12-21 | Liposomal Doxorubicin 40mg/m2 | N | N | 310009657 | LIPOSOMAL DOXORUBICIN |
| 310009142 | 310003960 | 1.83 | 102 | Palliative (P) | 2015-03-12 | 2015-03-12 | Liposomal Doxorubicin 40mg/m2 | N | null | 310009723 | LIPOSOMAL DOXORUBICIN |
| 310009143 | 310003962 | null | 91.2 | Palliative (P) | 2015-04-21 | 2015-04-22 | Trial Unspecified | N | null | 310009738 | TRIAL |
| 310009144 | 310003964 | 1.66 | null | Palliative (P) | 2015-03-01 | 2015-07-07 | Liposomal Doxorubicin 40mg/m2 | N | N | 310009799 | LIPOSOMAL DOXORUBICIN |
| 310009145 | 310007633 | 1.64 | 57.5 | Disease modification (D) | null | 2017-09-18 | CHOP - 21 days | N | N | 310009892 | CHOP |
| 310009146 | 310011514 | 1.65 | 71.2 | Palliative (P) | 2017-10-26 | 2017-10-26 | Trial Unspecified | N | N | 310009942 | TRIAL |
| 310009147 | 310003967 | 1.8 | 63 | Palliative (P) | 2014-08-08 | 2014-08-12 | CARBOPLATIN + GEMCITABINE | N | N | 310010052 | GEMCARBO |
| 310009148 | 310007634 | 1.55 | 63 | Palliative (P) | 2018-03-09 | 2018-03-13 | Trial Unspecified | N | N | 310010069 | TRIAL |
| 310009149 | 310003970 | 1.57 | 96.4 | Palliative (P) | 2017-02-04 | 2017-02-13 | CARBOPLATIN + GEMCITABINE | 2 | N | 310010128 | GEMCARBO |
| 310009150 | 310003972 | 1.67 | null | Palliative (P) | 2016-11-21 | 2016-11-26 | CHOP - 14 days | 02 | N | 310010225 | CHOP |
| 310009151 | 310003979 | 1.68 | 74.6 | Palliative (P) | 2017-01-23 | 2017-01-23 | Liposomal Doxorubicin 40mg/m2 | N | N | 310010231 | LIPOSOMAL DOXORUBICIN |
| 310009152 | 310007640 | 1.66 | null | Disease modification (D) | 2018-02-07 | 2018-02-13 | null | 02 | N | 310010243 | NOT MATCHED |
| 310009153 | 310007641 | 1.95 | 70.4 | null | 2018-10-02 | 2018-11-01 | LEAM | 2 | N | 310010291 | LEAM |
| 310009154 | 310003985 | 1.79 | 19.15 | Curative (C) | 2015-10-01 | 2015-10-10 | IVE | N | N | 310010311 | IVE |
| 310009155 | 310011515 | 0.84 | 81.9 | Neo-adjuvant (N) | 2016-06-02 | 2016-06-02 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | 02 | N | 310010323 | NOT MATCHED |
| 310009156 | 310003987 | 1.95 | 75 | Palliative (P) | 2014-02-11 | 2014-02-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310010407 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009159 | 310003989 | 1.98 | 78.4 | Palliative (P) | 2013-10-08 | 2013-10-14 | PEMBROLIZUMAB | null | N | 310010525 | PEMBROLIZUMAB |
| 310009160 | 310003993 | 1.9 | 104.9 | Palliative (P) | 2016-09-18 | 2016-10-10 | null | 02 | N | 310010528 | NOT MATCHED |
| 310009161 | 310003994 | 1.6 | 18 | Adjuvant (A) | 2016-07-23 | 2016-08-10 | Carboplatin + Liposomal Doxorubicin | N | null | 310010632 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009163 | 310007649 | 1.62 | 74 | Curative (C) | 2018-03-27 | 2018-03-28 | IVE | 2 | N | 310010664 | IVE |
| 310009164 | 310004001 | 1.61 | 60 | Curative (C) | 2014-06-30 | 2014-12-13 | IVE | 2 | N | 310010671 | IVE |
| 310009165 | 310004004 | 1.82 | 72.4 | Palliative (P) | null | 2015-02-18 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310010733 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009166 | 310007654 | 1.96 | 118 | Curative (C) | 2017-11-06 | 2017-11-12 | IVE | N | N | 310010747 | IVE |
| 310009169 | 310009585 | 1.58 | 89.1 | Palliative (P) | 2014-12-12 | 2014-12-13 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310010816 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009170 | 310007656 | null | 111.3 | null | 2014-02-13 | 2014-03-01 | IVE | N | N | 310010848 | IVE |
| 310009171 | 310004010 | 1.78 | 82.9 | Curative (C) | 2017-02-23 | 2017-02-23 | BEAM | 02 | N | 310010886 | BEAM |
| 310009172 | 310007658 | 1.8 | 75.6 | Palliative (P) | 2014-03-04 | 2015-08-26 | Carboplatin + Liposomal Doxorubicin | N | N | 310011027 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009173 | 310004014 | 1.96 | 84.7 | Curative (C) | 2015-07-27 | 2015-07-29 | IVE | 02 | N | 310011044 | IVE |